Learn about esketamine
How it works
Esketamine (brand name Spravato) is a form of ketamine given as a nasal spray. Most antidepressants work on serotonin or noradrenaline. Esketamine works on a different brain chemical, glutamate. It briefly blocks NMDA receptors, which leads to a burst of glutamate signalling through AMPA receptors. This switches on growth signals (such as BDNF) that help brain cells rebuild connections, especially in areas affected by long-standing depression. Some people notice improvement within days rather than weeks.
Possible benefits
- Works through a different pathway from standard antidepressants.
- In clinical trials, roughly half of people who had not responded to two or more antidepressants responded.
- Can work faster than tablets, sometimes within the first week or two.
- Given in clinic under supervision, so side effects are monitored.
Downsides and commitment
- Must be given in an approved treatment centre — you cannot take it home.
- Twice a week for the first 4 weeks, then weekly, then often every 1–2 weeks for months.
- You need to stay in clinic for monitoring (usually about 2 hours) and cannot drive until the next day after a proper night's sleep.
- Clinic session fees (nursing, monitoring, room) are not covered by Medicare or the PBS.
- It does not work for everyone; non-responders usually stop after 4 weeks.
PBS and Medicare rules
- Esketamine has been subsidised on the PBS since 1 May 2025 for adults with treatment-resistant depression.
- Treatment-resistant means major depression that has not responded well enough to at least two different antidepressants, each taken at an adequate dose for an adequate time, in the current moderate-to-severe episode.
- It is started alongside a newly started oral antidepressant, prescribed by (or under the supervision of) a psychiatrist.
- You pay the standard PBS co-payment per dose (lower with a concession card).
- To claim a Medicare rebate for psychiatrist consultations you need a current referral from your GP — please upload it with this request.
Side effects
- Common, usually within the first hour and settle the same day: feeling detached or dreamy (dissociation), dizziness, nausea, sleepiness, spinning sensation, numbness, headache, odd taste, anxiety.
- Blood pressure rises for a short time after each dose and is checked before and after.
- Less common: vomiting, feeling drunk, bladder symptoms, worsening mood or suicidal thoughts in the early weeks.
- Esketamine is a Schedule 8 (controlled) medicine because it can be misused.
Who it may not suit
- Aneurysm, a blood-vessel malformation in the brain, or a past bleed in the brain.
- A heart attack or other cardiovascular event in the last 6 weeks.
- Bipolar disorder, psychosis, or a current drug or alcohol problem (needs careful review).
- Pregnancy, planning pregnancy, or breastfeeding.
- Uncontrolled high blood pressure.
What a treatment day looks like
- No food for 2 hours and no drinks for 30 minutes beforehand.
- Blood pressure is checked.
- You give yourself the nasal spray under nurse supervision (2–3 devices, 5 minutes apart).
- You rest and are monitored until you are clinically ready to leave.
- Someone takes you home — no driving, cycling or machinery until the next day.
General information only, based on the Australian product information and PBS listing. Your psychiatrist will discuss whether this treatment is right for you.
Request an assessment
🔒 Sent securely to the clinic. Nothing is saved on this website, and no one else can see your answers.
Request sent
Thank you. The clinic will review your request and contact you to arrange an appointment. You may receive a confirmation email. Your information has not been saved on this website.
If things get worse while you wait, contact your GP, call Lifeline 13 11 14, or call 000 in an emergency.